• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牙科中的双膦酸盐:历史观点、不良反应和新应用。

Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications.

机构信息

Division of Periodontology, Diagnostic Sciences & Dental Hygiene, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, California, United States of America.

BioVinc LLC, Pasadena, California, United States of America.

出版信息

Bone. 2021 Jun;147:115933. doi: 10.1016/j.bone.2021.115933. Epub 2021 Mar 20.

DOI:10.1016/j.bone.2021.115933
PMID:33757899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8076070/
Abstract

Studies of the potential role of bisphosphonates in dentistry date back to physical chemical research in the 1960s, and the genesis of the discovery of bisphosphonate pharmacology in part can be linked to some of this work. Since that time, parallel research on the effects of bisphosphonates on bone metabolism continued, while efforts in the dental field included studies of bisphosphonate effects on dental calculus, caries, and alveolar bone loss. While some utility of this drug class in the dental field was identified, leading to their experimental use in various dentrifice formulations and in some dental applications clinically, adverse effects of bisphosphonates in the jaws have also received attention. Most recently, certain bisphosphonates, particularly those with strong bone targeting properties, but limited biochemical effects (low potency bisphosphonates), are being studied as a local remedy for the concerns of adverse effects associated with other more potent members of this drug class. Additionally, low potency bisphosphonate analogs are under study as vectors to target active drugs to the mineral surfaces of the jawbones. These latter efforts have been devised for the prevention and treatment of oral problems, such as infections associated with oral surgery and implants. Advances in the utility and mechanistic understanding of the bisphosphonate class may enable additional oral therapeutic options for the management of multiple aspects of dental health.

摘要

研究双膦酸盐在牙科中的潜在作用可以追溯到 20 世纪 60 年代的物理化学研究,双膦酸盐药理学的发现部分可以与这些工作联系起来。从那时起,对双膦酸盐对骨代谢影响的平行研究一直在继续,而在牙科领域的研究包括双膦酸盐对牙垢、龋齿和牙槽骨丢失的影响。虽然已经确定了该药物类别在牙科领域的一些用途,导致它们在各种牙膏配方和一些临床牙科应用中的实验性使用,但双膦酸盐在颌骨中的不良反应也受到了关注。最近,某些双膦酸盐,特别是那些具有强烈的骨靶向特性但生化作用有限(低效力双膦酸盐)的双膦酸盐,正在作为治疗与该药物类别中其他更有效成员相关的不良反应的局部治疗方法进行研究。此外,低效力双膦酸盐类似物也在作为载体研究中,将活性药物靶向到颌骨的矿物质表面。这些后期研究旨在预防和治疗口腔问题,如与口腔手术和植入物相关的感染。双膦酸盐类药物的应用和机制理解的进展可能为管理牙科健康的多个方面提供更多的口腔治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a269/8076070/affb050824f5/nihms-1685591-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a269/8076070/6ec28136e631/nihms-1685591-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a269/8076070/70ae45c42764/nihms-1685591-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a269/8076070/affb050824f5/nihms-1685591-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a269/8076070/6ec28136e631/nihms-1685591-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a269/8076070/70ae45c42764/nihms-1685591-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a269/8076070/affb050824f5/nihms-1685591-f0003.jpg

相似文献

1
Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications.牙科中的双膦酸盐:历史观点、不良反应和新应用。
Bone. 2021 Jun;147:115933. doi: 10.1016/j.bone.2021.115933. Epub 2021 Mar 20.
2
Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.口服双膦酸盐类药物患者植入牙种植体的疗效:115例病例回顾
J Oral Maxillofac Surg. 2008 Feb;66(2):223-30. doi: 10.1016/j.joms.2007.09.019.
3
Bisphosphonate and Implant Dentistry - Is it Safe?双膦酸盐与种植牙科——安全吗?
Prim Dent J. 2015 Aug;4(3):30-3. doi: 10.1308/205016815815944650.
4
Bisphosphonates: Clinical Applications and Adverse Events in Dentistry.双膦酸盐:牙科临床应用及不良事件
Oral Health Prev Dent. 2015;13(4):289-99. doi: 10.3290/j.ohpd.a34370.
5
Dental implications of bisphophonate-related osteonecrosis.双膦酸盐相关性骨坏死的口腔医学相关问题。
Gerodontology. 2012 Sep;29(3):177-87. doi: 10.1111/j.1741-2358.2012.00622.x. Epub 2012 Apr 9.
6
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.双膦酸盐减少 3B+期慢性肾脏病的骨折:倾向评分匹配队列研究。
Health Technol Assess. 2021 Mar;25(17):1-106. doi: 10.3310/hta25170.
7
Bisphosphonate therapy for osteogenesis imperfecta.用于成骨不全的双膦酸盐治疗
Cochrane Database Syst Rev. 2014 Jul 23(7):CD005088. doi: 10.1002/14651858.CD005088.pub3.
8
Bisphosphonate therapy for osteogenesis imperfecta.用于成骨不全症的双膦酸盐治疗
Cochrane Database Syst Rev. 2016 Oct 19;10(10):CD005088. doi: 10.1002/14651858.CD005088.pub4.
9
A review of the clinical implications of bisphosphonates in dentistry.双膦酸盐在牙科中的临床意义综述。
Aust Dent J. 2011 Mar;56(1):2-9. doi: 10.1111/j.1834-7819.2010.01283.x. Epub 2010 Dec 22.
10
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003474. doi: 10.1002/14651858.CD003474.pub2.

引用本文的文献

1
Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004-2023).使用FAERS数据库(2004 - 2023年)对口服双膦酸盐相关食管毒性进行的不成比例分析。
Front Pharmacol. 2024 Nov 7;15:1473756. doi: 10.3389/fphar.2024.1473756. eCollection 2024.
2
Untreated osteoporosis and higher FRAX as risk factors for tooth loss: a 5-year prospective study.未经治疗的骨质疏松症和较高的 FRAX 是牙齿缺失的危险因素:一项为期 5 年的前瞻性研究。
J Bone Miner Metab. 2023 Sep;41(5):727-737. doi: 10.1007/s00774-023-01451-w. Epub 2023 Jul 11.
3
Osteonecrosis of the jaws in patients under osteoporosis treatment: a nine-year experience report.

本文引用的文献

1
Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen Treated with Novel Bisphosphonate-Fluoroquinolone Antimicrobial Conjugates.新型双膦酸盐-氟喹诺酮抗菌偶联物治疗骨髓炎生物膜病原体的生长和抑制的实时阻抗监测。
Int J Mol Sci. 2023 Jan 19;24(3):1985. doi: 10.3390/ijms24031985.
2
Shotgun metagenome sequencing identification of a set of genes encoded by Actinomyces associated with medication-related osteonecrosis of the jaw.通过 shotgun 宏基因组测序鉴定与药物相关性颌骨坏死相关的放线菌编码的一组基因。
PLoS One. 2020 Nov 30;15(11):e0241676. doi: 10.1371/journal.pone.0241676. eCollection 2020.
3
骨质疏松症治疗患者的颌骨坏死:九年经验报告。
Arch Endocrinol Metab. 2023 May 12;67(4):e000612. doi: 10.20945/2359-3997000000612.
4
Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review).双膦酸盐作为生物瓣钙化潜在抑制剂的研究进展(综述)。
Sovrem Tekhnologii Med. 2022;14(2):68-78. doi: 10.17691/stm2022.14.2.07. Epub 2022 Mar 28.
5
Biofouling in Membrane Bioreactors-Mitigation and Current Status: a Review.膜生物反应器中的生物污染——缓解与现状综述
Appl Biochem Biotechnol. 2023 Sep;195(9):5643-5668. doi: 10.1007/s12010-022-04262-3. Epub 2022 Nov 23.
6
Bisphosphonates for delivering drugs to bone.双膦酸盐类药物用于骨靶向给药。
Br J Pharmacol. 2021 May;178(9):2008-2025. doi: 10.1111/bph.15251. Epub 2021 Apr 10.
Pyrophosphates in toothpaste: a retrospective and reappraisal.
牙膏中的焦磷酸盐:回顾与再评价。
Br Dent J. 2020 Nov;229(10):687-689. doi: 10.1038/s41415-020-2346-4. Epub 2020 Nov 27.
4
Pharmacologic management of metastatic bone disease.转移性骨病的药物治疗管理。
Bone. 2022 May;158:115735. doi: 10.1016/j.bone.2020.115735. Epub 2020 Nov 7.
5
Bisphosphonates for delivering drugs to bone.双膦酸盐类药物用于骨靶向给药。
Br J Pharmacol. 2021 May;178(9):2008-2025. doi: 10.1111/bph.15251. Epub 2021 Apr 10.
6
Microbial Etiology and Prevention of Dental Caries: Exploiting Natural Products to Inhibit Cariogenic Biofilms.龋齿的微生物病因及预防:利用天然产物抑制致龋生物膜
Pathogens. 2020 Jul 14;9(7):569. doi: 10.3390/pathogens9070569.
7
Spontaneous oral ulceration with bone sequestration: its relevance in current clinical practice.伴有骨质坏死的自发性口腔溃疡:其在当前临床实践中的相关性。
Br J Oral Maxillofac Surg. 2020 Nov;58(9):e75-e79. doi: 10.1016/j.bjoms.2020.06.030. Epub 2020 Jul 7.
8
Targeting anti-cancer agents to bone using bisphosphonates.使用双膦酸盐将抗癌药物靶向输送至骨骼。
Bone. 2020 Sep;138:115492. doi: 10.1016/j.bone.2020.115492. Epub 2020 Jun 23.
9
Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors.通过预防性牙科护理和了解风险因素来减轻颌骨骨坏死(ONJ)。
Bone Res. 2020 Mar 11;8:14. doi: 10.1038/s41413-020-0088-1. eCollection 2020.
10
The effect of bisphosphonate discontinuation on the incidence of postoperative medication-related osteonecrosis of the jaw after tooth extraction.双膦酸盐停药对拔牙术后药物相关性颌骨坏死发生率的影响。
J Korean Assoc Oral Maxillofac Surg. 2020 Feb;46(1):78-83. doi: 10.5125/jkaoms.2020.46.1.78. Epub 2020 Feb 26.